AstraZeneca Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Date | Value | Name | Entity | Role | Shares | Max Price |
---|---|---|---|---|---|---|
22 Nov 23 | BuyCHF224,324 | Michel Demare | Individual | 2,000 | CHF112.21 |
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Owner Type | Number of Shares | Ownership Percentage |
---|---|---|
Individual Insiders | 729,365 | 0.047% |
Public Companies | 777,613 | 0.0502% |
Private Companies | 1,892,363 | 0.122% |
State or Government | 2,368,774 | 0.153% |
General Public | 430,779,874 | 27.8% |
Institutions | 1,113,683,095 | 71.8% |
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Top Shareholders
Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
---|---|---|---|---|---|---|
132,015,351 | CHF18.1b | -1.89% | 0.37% | |||
113,047,040 | CHF15.5b | -1.23% | 1.03% | |||
67,155,711 | CHF9.2b | 1.34% | 0.18% | |||
57,587,700 | CHF7.9b | -0.49% | 1.83% | |||
51,587,810 | CHF7.1b | 0% | 12.16% | |||
34,644,764 | CHF4.7b | 0.25% | 0.47% | |||
27,320,760 | CHF3.7b | 0.09% | 0.7% | |||
26,175,035 | CHF3.6b | 1.26% | 0.83% | |||
25,821,555 | CHF3.5b | -0.11% | 0.33% | |||
25,458,559 | CHF3.5b | 0.03% | 0.16% | |||
19,095,678 | CHF2.6b | -0.83% | 3.49% | |||
18,900,643 | CHF2.6b | 5.04% | 0.43% | |||
16,842,855 | CHF2.3b | 19.4% | 0.56% | |||
16,581,230 | CHF2.3b | 1.44% | 1.35% | |||
13,616,076 | CHF1.9b | -4.96% | 1.35% | |||
12,530,044 | CHF1.7b | -1.13% | 0.24% | |||
12,284,525 | CHF1.7b | 6.96% | 2.67% | |||
11,386,858 | CHF1.6b | -0.16% | 2.25% | |||
10,213,248 | CHF1.4b | -3.22% | 1.26% | |||
9,330,068 | CHF1.3b | -1.86% | 0.66% | |||
9,262,615 | CHF1.3b | -0.14% | 0.26% | |||
8,690,208 | CHF1.2b | 0.82% | 0.41% | |||
8,486,821 | CHF1.2b | -4.15% | 0.38% | |||
7,765,802 | CHF1.1b | 2.15% | 0.36% | |||
7,323,603 | CHF1.0b | 3.05% | 0.09% |